article thumbnail

Tech Moves: Adaptive Biotechnologies COO departing; Sana adds leaders; and more

GeekWire

Adaptive Photo) — Mark Adams is stepping down as chief operating officer of Adaptive Biotechnologies , the company said today in a regulatory filing. Sana Biotechnology named two new research leaders. Members include: Sonoma co-founder Alexander Rudensky , chair of the immunology program at the Sloan Kettering Institute.

article thumbnail

Sana Biotechnology will cut 15% of its workforce in latest layoffs affecting Seattle companies

GeekWire

Seattle-based cell and gene therapy company Sana Biotechnology will reduce its workforce by 15%, according to a statement issued Tuesday. The company said it was shutting a program focused on heart failure and outlined reset priorities for other programs. Sana CEO Steve Harr. Sana Photo).

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Adaptive Biotechnologies lays off about 100 people, 12% of headcount, to ‘streamline our workforce’

GeekWire

Chad Robins, left, is co-founder and CEO of Adaptive Biotechnologies, which he co-founded with his brother, Harlan Robins, right, the company’s chief scientific officer. Adaptive Biotechnologies Photo). Adaptive Biotechnologies is laying off 12% of its workforce, or about 100 employees, GeekWire has learned. “We

article thumbnail

Seattle biotech startup Sana Biotechnology will develop 163K square-foot facility in the Bay Area

GeekWire

Sana Biotechnology , a young and fast-growing Seattle-based biotech, has chosen the San Francisco Bay Area as the site for its new biomanufacturing facility. The company currently has multiple pre-clinical programs but has not yet entered a product into clinical trials. (Sana Photo).

article thumbnail

Sana Biotechnology inks $50M deal for precise gene editing system from Beam Therapeutics

GeekWire

Sana Biotechnology has a new $50 million tool in its toolbox. Gene editing technology is a key component in developing engineered cells as medicines, and we are pleased to have the ability to use the Cas12b system as part of a number of our ex vivo engineered cell programs,” said Steve Harr , Sana’s president and CEO in a statement.

article thumbnail

Adaptive Biotechnologies’ new HQ: Co-founders show off 100K square-foot space in Seattle

GeekWire

Adaptive co-founders Harlan (left) and Chad Robins on the plaza at the new Adaptive Biotechnology headquarters. After doubling its workforce during the pandemic, Adaptive Biotechnologies finally has room to grow. Harlan, former head of the the computational biology program at Fred Hutch, serves as chief scientific officer.

article thumbnail

Tech Moves: Adaptive Biotech co-founders join life sciences SPAC; new edtech execs; and more

GeekWire

Chad Robins, left, is co-founder and CEO of Adaptive Biotechnologies, which he co-founded with his brother, Harlan Robins, right, a theoretical physicist turned computational biologist who is the company’s chief scientific officer. Adaptive Biotechnologies Photo). Lance Solomon.